WallStreetZenWallStreetZen

NASDAQ: THRD
Third Harmonic Bio Inc Earnings & Revenue

THRD earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$29.6M
Current Profit Margin
0%

THRD Return on Equity

Current Company
-10.9%
Current Industry
16.6%
Current Market
30.8%
THRD's Return on Equity (-10.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when THRD announces earnings.

THRD Return on Assets

Current Company
-10.6%
Current Industry
3.1%
THRD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

THRD Return on Capital Employed

Current Company
-11.1%
Current Industry
-43.5%

THRD vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
THRD$0.00-$28.88M-$29.60MN/AN/A
ORIC$0.00-$100.72M-$101.76MN/AN/A
EYPT$50.02M-$77.74M-$78.92M+54.65%N/A
SVRA$0.00-$60.60M-$64.49M-100.00%N/A
IGMS$2.11M-$222.04M-$236.92M+32.31%N/A

Third Harmonic Bio Earnings & Revenue FAQ

What were THRD's earnings last quarter?

On Invalid Date, Third Harmonic Bio (NASDAQ: THRD) reported Q1 2024 earnings per share (EPS) of -$0.20, up 13.04% year over year. Total Third Harmonic Bio earnings for the quarter were -$7.86 million. In the same quarter last year, Third Harmonic Bio's earnings per share (EPS) was -$0.23.

If you're new to stock investing, here's how to buy Third Harmonic Bio stock.

What was THRD's earnings growth in the past year?

As of Q2 2024, Third Harmonic Bio's earnings has grown year over year. Third Harmonic Bio's earnings in the past year totalled -$29.60 million.

What was THRD's revenue last quarter?

On Invalid Date, Third Harmonic Bio (NASDAQ: THRD) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Third Harmonic Bio's revenue was $0.00.

What was THRD's revenue growth in the past year?

As of Q2 2024, Third Harmonic Bio's revenue has grown null year over year. Third Harmonic Bio's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.